Home > Healthcare > Biotechnology > Biopharma > Microbiome Diagnostics Market

Microbiome Diagnostics Market Size

Report ID: GMI9140
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Microbiome Diagnostics Market Size

Microbiome Diagnostics Market size was valued at around USD 143.1 million in 2023 and is estimated to grow at 13.4% CAGR from 2024 to 2032. Microbiome diagnostics refers to the application of advanced technologies and analytical methods to characterize and analyze the composition, diversity, and functional attributes of microbial communities residing within the human body, environmental samples, or other habitats.

To get key market trends

Download Free Sample

It encompasses the identification, quantification, and profiling of microorganisms including bacteria, archaea, viruses, fungi, and other microbes using techniques such as next-generation sequencing, metagenomics, metatranscriptomics, metabolomics, and bioinformatics analysis. The increasing prevalence of chronic disease diseases includes cardiovascular diseases, diabetes, and cancer serves as a substantial impetus for market growth. For instance, according to the World Health Organization (WHO), in 2022, there were an estimated 20 million new cancer cases and 9.7 million deaths from cancer worldwide. Thus, the advancement and widespread adoption of microbiome diagnostics are essential for enhancing the diagnosis, treatment management, and risk prediction of cancer.

Furthermore, rising demand of personalized medicine, growing awareness about importance of human microbiomes, and rising funding & investments in microbiome research are the contributing factors stimulating the market growth.

Microbiome Diagnostics Market Report Attributes
Report Attribute	Details
Base Year:	2023
Microbiome Diagnostics Market Size in 2023:	USD 143.1 Million
Forecast Period:	2024 to 2032
Forecast Period 2024 to 2032 CAGR:	13.4%
2032 Value Projection:	USD 429.2 Million
Historical Data for:	2021 - 2023
No. of Pages:	250
Tables, Charts & Figures:	347
Segments covered:	Product, Technology, Sample, Application, End-use, and Region
Growth Drivers:	Increasing prevalence of chronic diseases Rising demand of personalized medicine Growing awareness about importance of human microbiomes Rising funding and investments in microbiome research
Pitfalls & Challenges:	High cost associated with microbiome testing

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Microbiome diagnostics market size was USD 143.1 million in 2023 and is expected to register 13.4% CAGR from 2024-2032 owing to the increasing prevalence of chronic disease diseases including cardiovascular diseases, diabetes, and cancer worldwide.

The kits and reagents segment is expected to reach USD 296.6 million by 2032 due to providing standardized protocols and formulations ensuring consistency and reproducibility in microbiome sample preparation.

The U.S. microbiome diagnostics industry is expected to register 13.1% CAGR from 2024-2032 due to presence of world-renowned research institutions, academic centers, and biotechnology companies at the forefront of microbiome research in the country.

Genetic Analysis AS, Illumina, Inc., Microba Life Sciences Limited, Micronoma, Inc., OraSure Technologies, Inc., Oxford Nanopore Technologies plc, Quantbiome, Inc., and ViennaLab Diagnostics GmbH, are some of the major microbiome diagnostics companies worldwide.